-
1
-
-
34249653034
-
Translational research: Advancing medical science by stimulating interdisciplinary research
-
Foon KA. Translational research: advancing medical science by stimulating interdisciplinary research. Exp Biol Med 2007; 232: 713-714.
-
(2007)
Exp Biol Med
, vol.232
, pp. 713-714
-
-
Foon, K.A.1
-
2
-
-
52149094119
-
The role of translational research in addressing health disparities: A conceptual frame work
-
Fleming ES, Perkins K, Easa D, Conde JG, Baker RS, Southerland WM, et al. The role of translational research in addressing health disparities: a conceptual frame work. Ethn Dis 2008; 18(2 suppl 2): S2150-S2160.
-
(2008)
Ethn Dis
, vol.18
, Issue.2 SUPPL. 2
-
-
Fleming, E.S.1
Perkins, K.2
Easa, D.3
Conde, J.G.4
Baker, R.S.5
Southerland, W.M.6
-
3
-
-
71049116868
-
The infectious diseases biobank at king's college London: Archiving samples from patients infected with HIV to facilitate translational research
-
Williams R, Mant C, Cason J. The infectious diseases biobank at king's college London: archiving samples from patients infected with HIV to facilitate translational research. Retrovirology 2009; 6: 98.
-
(2009)
Retrovirology
, vol.6
, pp. 98
-
-
Williams, R.1
Mant, C.2
Cason, J.3
-
5
-
-
77950832811
-
Personal electronic health records: From biomedical research to people's health
-
Roberts J. Personal electronic health records: from biomedical research to people's health. Inform Prim Care 2009; 17: 255-260.
-
(2009)
Inform Prim Care
, vol.17
, pp. 255-260
-
-
Roberts, J.1
-
6
-
-
33845354052
-
Trends in ethical and legal frameworks for the use of human biobanks
-
Cambon-Thomsen A, Rial-Sebbag E, Knoppers BM. Trends in ethical and legal frameworks for the use of human biobanks. Eur Respir J 2007; 30: 373-382.
-
(2007)
Eur Respir J
, vol.30
, pp. 373-382
-
-
Cambon-Thomsen, A.1
Rial-Sebbag, E.2
Knoppers, B.M.3
-
7
-
-
77953261364
-
Translational bioinformatics and healthcare informatics: Computational and ethical challenges
-
Sethi P, Theodos K. Translational bioinformatics and healthcare informatics: computational and ethical challenges. Perspect Health Inf Manag 2009; 16: 1-13.
-
(2009)
Perspect Health Inf Manag
, vol.16
, pp. 1-13
-
-
Sethi, P.1
Theodos, K.2
-
8
-
-
58249140297
-
Pharmacokinetics of 8-hour intravenous infusion of NXY-059: A phase I, randomized, double-blind (within dose panels), placebo-controlled study in healthy Chinese volunteers
-
Cheng YF, Jiang J, Hu P, Reinholdsson I, Guo W, Asenblad N. Pharmacokinetics of 8-hour intravenous infusion of NXY-059: A phase I, randomized, double-blind (within dose panels), placebo-controlled study in healthy Chinese volunteers. Clin Ther 2008; 30: 2342-2353.
-
(2008)
Clin Ther
, vol.30
, pp. 2342-2353
-
-
Cheng, Y.F.1
Jiang, J.2
Hu, P.3
Reinholdsson, I.4
Guo, W.5
Asenblad, N.6
-
9
-
-
33845878521
-
Pharma faces major challenges after a year of failures and heated battles
-
Frantz S. Pharma faces major challenges after a year of failures and heated battles. Nat Rev Drug Discov 2007; 6: 5-7.
-
(2007)
Nat Rev Drug Discov
, vol.6
, pp. 5-7
-
-
Frantz, S.1
-
10
-
-
0142089747
-
Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer
-
Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao GP, et al. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer. Mol Genet Metab 2003; 80: 148-158.
-
(2003)
Mol Genet Metab
, vol.80
, pp. 148-158
-
-
Raper, S.E.1
Chirmule, N.2
Lee, F.S.3
Wivel, N.A.4
Bagg, A.5
Gao, G.P.6
-
11
-
-
34548152541
-
Trastuzumab-related cardiotoxicity: Calling into question the concept of reversibility
-
Telli ML, Hunt SA, Carlson RW, Guardino AE. Trastuzumab-related cardiotoxicity: calling into question the concept of reversibility. Clin Oncol 2007; 25:3525-3533.
-
(2007)
Clin Oncol
, vol.25
, pp. 3525-3533
-
-
Telli, M.L.1
Hunt, S.A.2
Carlson, R.W.3
Guardino, A.E.4
-
12
-
-
34347369232
-
Angiogenesis inhibition in the treatment of lung cancer
-
Vokes E, Herbst R, Sandler A. Angiogenesis inhibition in the treatment of lung cancer. Clin Adv Hematol Oncol 2006; 4(11 Suppl 23):1-10.
-
(2006)
Clin Adv Hematol Oncol
, vol.4
, Issue.11 SUPPL. 23
, pp. 1-10
-
-
Vokes, E.1
Herbst, R.2
Sandler, A.3
-
13
-
-
70350724766
-
Thrombotic events in patients with cancer receiving antiangiogenesis agents
-
Zangairi M, Fink LM, Elice F, Zhan F, Adcock DM, Tricot GJ. Thrombotic events in patients with cancer receiving antiangiogenesis agents. J Clin Oncol 2009; 27: 4865-4873.
-
(2009)
J Clin Oncol
, vol.27
, pp. 4865-4873
-
-
Zangairi, M.1
Fink, L.M.2
Elice, F.3
Zhan, F.4
Adcock, D.M.5
Tricot, G.J.6
-
14
-
-
77955476115
-
Bleeding complications of antiangiogenic therapy: Pathogenetic mechanisms and clinical impact
-
Elice F, Rodeghiero F. Bleeding complications of antiangiogenic therapy: pathogenetic mechanisms and clinical impact. Thromb Res 2010; 125 Suppl 2: S55-S57.
-
(2010)
Thromb Res
, vol.125
, Issue.SUPPL. 2
-
-
Elice, F.1
Rodeghiero, F.2
-
16
-
-
37749032491
-
Cytokine storm in the phase I trial of monoclonal antibody TGN1412: Better understanding the causes to improve preclinical testing of immunotherapeutics
-
Stebbings R, Findlay L, Edwards C, Eastwood D, Bird C, North D, et al. Cytokine storm in the phase I trial of monoclonal antibody TGN1412: better understanding the causes to improve preclinical testing of immunotherapeutics. J Immunol 2007; 179: 3325-3331.
-
(2007)
J Immunol
, vol.179
, pp. 3325-3331
-
-
Stebbings, R.1
Findlay, L.2
Edwards, C.3
Eastwood, D.4
Bird, C.5
North, D.6
-
18
-
-
33845878521
-
Pharma faces major challenges after a year of failures and heated battles
-
Frantz S. Pharma faces major challenges after a year of failures and heated battles. Nat Rev Drug Discov 2007; 6: 5-7.
-
(2007)
Nat Rev Drug Discov
, vol.6
, pp. 5-7
-
-
Frantz, S.1
-
19
-
-
77956302693
-
Primate testing of TGN1412: Right target, wrong cell
-
Pallardy M, Hünig T. Primate testing of TGN1412: right target, wrong cell. Br J Pharmacol 2010; 161: 509-551.
-
(2010)
Br J Pharmacol
, vol.161
, pp. 509-551
-
-
Pallardy, M.1
Hünig, T.2
-
20
-
-
74249091457
-
Technical and policy approaches to balancing patient privacy and data sharing in clinical and translational research
-
Malin B, Karp D, Scheuermann RH. Technical and policy approaches to balancing patient privacy and data sharing in clinical and translational research. J Investig Med 2010; 58: 11-18.
-
(2010)
J Investig Med
, vol.58
, pp. 11-18
-
-
Malin, B.1
Karp, D.2
Scheuermann, R.H.3
-
21
-
-
38349095115
-
Innovative early development regulatory approaches: ExpIND, expCTA, microdosing
-
Robinson, WT. Innovative early development regulatory approaches: expIND, expCTA, microdosing. Clin Pharmacol Ther 2008; 83: 358-360.
-
(2008)
Clin Pharmacol Ther
, vol.83
, pp. 358-360
-
-
Robinson, W.T.1
-
22
-
-
34548324267
-
The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials
-
Marchetti S, Schellens JH. The impact of FDA and EMEA guidelines on drug development in relation to Phase 0 trials. Br J Cancer 2007; 97: 577-581.
-
(2007)
Br J Cancer
, vol.97
, pp. 577-581
-
-
Marchetti, S.1
Schellens, J.H.2
-
23
-
-
80053513705
-
Disasters Waiting to Happen, Principles and Practice of Clinical Research
-
Goldstein B. Scenario: Disasters waiting to happen. Principles and practice of clinical research. Burlington: Elsevier; 2007: 292-293.
-
(2007)
Burlington. Elsevier
, pp. 292-293
-
-
Goldstein, B.1
-
25
-
-
73949136029
-
The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: A retrospective of the last decade
-
Weigelt B, Baehner FL, Reis-Filho JS. The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade. J Pathol 2010; 220: 263-280.
-
(2010)
J Pathol
, vol.220
, pp. 263-280
-
-
Weigelt, B.1
Baehner, F.L.2
Reis-Filho, J.S.3
-
26
-
-
52649091291
-
Recent progress on normal and malignant pancreatic stem/progenitor cell research: Therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer
-
Mimeault M, Batra SK. Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer. Gut 2008; 57: 1456-1468.
-
(2008)
Gut
, vol.57
, pp. 1456-1468
-
-
Mimeault, M.1
Batra, S.K.2
-
27
-
-
35648999534
-
Recent advances in cancer stem/progenitor cell research: Therapeutic implications for overcoming resistance to the most aggressive cancers
-
Mimeault M, Hauke R, Mehta PP, Batra SK. Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med 2007; 11: 981-1011.
-
(2007)
J Cell Mol Med
, vol.11
, pp. 981-1011
-
-
Mimeault, M.1
Hauke, R.2
Mehta, P.P.3
Batra, S.K.4
-
28
-
-
77349091545
-
Biological and clinical significance of KRAS mutations in lung cancer: An oncogenic driver that contrasts with EGFR mutation
-
Suda K, Tomizawa K, Mitsudomi T. Biological and clinical significance of KRAS mutations in lung cancer: an oncogenic driver that contrasts with EGFR mutation. Cancer Metastasis Rev 2010; 29: 49-60.
-
(2010)
Cancer Metastasis Rev
, vol.29
, pp. 49-60
-
-
Suda, K.1
Tomizawa, K.2
Mitsudomi, T.3
-
29
-
-
74249097210
-
Recent insights into the pathogenesis of colorectal cancer
-
Goel A, Boland CR. Recent insights into the pathogenesis of colorectal cancer. Curr Opin Gastroenterol 2010; 26: 47-52.
-
(2010)
Curr Opin Gastroenterol
, vol.26
, pp. 47-52
-
-
Goel, A.1
Boland, C.R.2
|